Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIG1 | P18858 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8637600 | 0.85 | LIG1 (0.47) | LIG1HPGDTSHRMAPK1HSD17B10 | |
| 1,2-Diallyloxybenzene SCHEMBL366516 | 0.84 | HPGD (0.60) | LIG1HPGDTSHRMAPK1HSD17B10 | |
| 1,2-Diallyloxybenzene SCHEMBL29768784 | 0.84 | HPGD (0.60) | LIG1HPGDTSHRMAPK1HSD17B10 | |
| SCHEMBL8637602 | 0.81 | LIG1 (0.44) | LIG1HPGDTSHRMAPK1HSD17B10 | |
| 1-Allyloxy-2-Ethoxybenzene SCHEMBL11755537 | 0.79 | HPGD (0.51) | LIG1HPGDTSHRMAPK1HSD17B10 | |
| SCHEMBL10509104 | 0.79 | LIG1 (0.53) | LIG1HPGDTSHRMAPK1HSD17B10 | |
| SCHEMBL3800333 | 0.78 | HPGD (0.55) | LIG1HPGDTSHRMAPK1HSD17B10 | |
| SCHEMBL7764770 | 0.78 | HPGD (0.55) | LIG1HPGDTSHRMAPK1HSD17B10 | |
| SCHEMBL5611747 | 0.78 | HPGD (0.50) | LIG1HPGDTSHRMAPK1HSD17B10 | |
| SCHEMBL6575619 | 0.78 | HPGD (0.50) | LIG1HPGDTSHRMAPK1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5339109-A | — | — | None | — | — | JP | disclosed |
| JP-59216847-A | — | — | None | — | — | JP | disclosed |
| JP-8133912-A | — | — | None | — | — | JP | disclosed |
| US-20230405155-A1 | NANOPARTICLE, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPY DRUG, AND PHOTOTHERMAL THERAPY DRUG | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-12-21 | — | — | US | disclosed |
| EP-4241846-A1 | NANOPARTICLES, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPEUTIC AGENT, AND PHOTOTHERMAL THERAPEUTIC AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-09-13 | — | — | EP | disclosed |
| WO-2023101004-A1 | OLEFIN RESIN, METHOD FOR MANUFACTURING SAME, AND APPLICATION FOR SAME | 三井化学株式会社 | 2023-06-08 | — | — | WO | disclosed |
| EP-3442045-B1 | ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND SOLAR BATTERY MODULE AND SENSOR PROVIDED WITH SAME | SUMITOMO CHEMICAL CO (JP) | 2022-01-12 | — | — | EP | disclosed |
| WO-2021161793-A1 | POLYMER, COMPOSITION, INK, AND PHOTOELECTRIC CONVERSION ELEMENT | 住友化学株式会社 | 2021-08-19 | — | — | WO | disclosed |
| US-11063219-B2 | Organic photoelectric conversion element, and solar cell module and sensor provided with the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-07-13 | — | — | US | disclosed |
| US-10290809-B2 | Macromolecular compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-05-14 | — | — | US | disclosed |
| WO-2006109198-A2 | METHODS FOR OBTAINING OPTICALLY ACTIVE GLYCIDYL ETHERS AND OPTICALLY ACTIVE VICINAL DIOLS FROM RACEMIC SUBSTRATES | OXYRANE UK LIMITED (GB) | 2006-10-19 | — | — | WO | disclosed |
| WO-2005100587-A2 | METHODS FOR OBTAINING OPTICALLY ACTIVE EPOXIDES AND VICINAL DIOLS FROM 2,2-DISUBSTITUTED EPOXIDES | CSIR (ZA) | 2005-10-27 | — | — | WO | disclosed |
| WO-2005100569-A2 | METHODS FOR THE PREPARATION OF OPTICALLY ACTIVE EPOXIDES AND VICINAL DIOLS FROM STYRENE EPOXIDES USING ENANTIOSELECTIVE EPOXIDE HYDROLASES DERIVED FROM YEASTS | CSIR (ZA) | 2005-10-27 | — | — | WO | disclosed |
| WO-2005100578-A2 | METHODS FOR OBTAINING OPTICALLY ACTIVE EPOXIDES AND VICINAL DIOLS FROM MESO-EPOXIDES | CSIR (ZA) | 2005-10-27 | — | — | WO | disclosed |
| EP-0611826-B1 | Processes for production of optically active epoxides | DAICEL CHEM (JP) | 2003-05-02 | — | — | EP | disclosed |
| US-5672504-A | TREATING MIXED EPOXIDE ENANTIOMORPHS WITH MICROORGANISMS TO INCREASE CONCENTRATION OF OPTICALLY PURE S-ENANTIOMORPHS | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1997-09-30 | — | — | US | disclosed |
| JP-H08133912-A | HERBICIDAL COMPOSITION AND WEEDING | NIPPON NOHYAKU CO LTD | 1996-05-28 | — | — | JP | disclosed |
| EP-0611826-A2 | Processes for production of optically active epoxides | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1994-08-24 | — | — | EP | disclosed |
| JP-H05339109-A | HERBICIDE COMPOSITION | IDEMITSU KOSAN CO LTD | 1993-12-21 | — | — | JP | disclosed |
| JP-S59216847-A | POLYETHER DERIVATIVE USEFUL AS IONOPHORE | AGENCY OF IND SCIENCE & TECHNOL | 1984-12-06 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230405155-A1 | NANOPARTICLE, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPY DRUG, AND PHOTOTHERMAL THERAPY DRUG | CRY2, RB1, NR2E3 | LIG1 3280/4885HPGD 3689/4885TSHR 331/4885 |
| US-10290809-B2 | Macromolecular compound | EXOSC4, TRPC6, MRPS22 | LIG1 2394/4885HPGD 4858/4885TSHR 1066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.